Productivity costs in cost-effectiveness analysis: Numerator or denominator: A further discussion

Health Economics

Volumn 6, Issue 5, 1997, Pages 511-514

  Brouwer, Werner B F ^a   Koopmanschap, Marc A ^a   Rutten, Frans F H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EMPLOYER; LEISURE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; SHORT SURVEY; SOCIETY;

COST OF ILLNESS; COST-BENEFIT ANALYSIS; EFFICIENCY; EMPLOYMENT; HEALTH SERVICES RESEARCH; HUMANS; LEISURE ACTIVITIES; MODELS, ECONOMETRIC; QUALITY-ADJUSTED LIFE YEARS;

EID: 0030712218     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1050(199709)6:5<511::AID-HEC297>3.0.CO;2-K     Document Type: Short Survey

References (7)

1. Weinstein, M. C., Siegel, J. E., Garber, A. M., Lipscomb, J., Luce, B. R., Manning, W. G., Jr, and Torrance, G. W., Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group. Health Econ. in press.
2. Brouwer, W. B. F., Koopmanschap, M. A. and Rutten, F. F. H. Productivity costs measurement through quality of life? A response to the recommendations of the Washington Panel. Health Econ. 1997; 6: 253-259.
3. Gold, M. R., Siegel, J. E., Russell, L. B. and Weinstein, M. C. (eds), Cost-Effectiveness in Health and Medicine. Oxford: Oxford University Press, 1996.
4. Russell, L. B., Gold, M. R., Siegel, J. E., Daniels, N. and Weinstein, M. C.. The role of cost-effectiveness analysis in health and medicine. J. Am. Med. Assoc. 1996; 276: 1172-1177.
5. Weinstein, M. C., Siegel, J. E., Gold, M. R., Kamlet, M. S. and Russell, L. B. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. J. Am. Med. Assoc. 1996; 276: 1253-258.
6. Koopmanschap, M. A., Rutten, F. F. H., van Ineveld, B. M. and van Roijen, L. The friction cost method for measuring indirect costs of disease. Journal of Health Economics 1995; 14; 171-189.
7. Johannesson, M., Avoiding double-counting in pharmacoeconomic studies. PharmacoEconomics 1997; 11: 385-388.